Previous Article | Next Article 
Infection and Immunity, December 2008, p. 5754-5759, Vol. 76, No. 12
0019-9567/08/$08.00+0 doi:10.1128/IAI.00497-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Schistosoma mansoni Egg Antigen-Mediated Modulation of Toll-Like Receptor (TLR)-Induced Activation Occurs Independently of TLR2, TLR4, and MyD88
Colleen M. Kane,
Euihye Jung, and
Edward J. Pearce*
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
Received 22 April 2008/
Returned for modification 27 May 2008/
Accepted 28 August 2008

ABSTRACT
Unlike most pathogens, helminth parasites and their products
induce strong Th2 responses, and dendritic cells (DCs) and macrophages
exposed to helminth antigens generally fail to produce interleukin-12.
Rather, it has been shown that helminth products such as soluble
egg antigens (SEA; a soluble extract from
Schistosoma mansoni eggs) inhibit the activation of DCs in response to classical
Toll-like receptor (TLR) ligands such as lipopolysaccharide
or CpG. Nevertheless, recent work has suggested that TLR4 and/or
TLR2 plays an important role in the recognition of helminth
products by DCs and macrophages and in the development of Th2
responses. Using DCs derived from TLR4
–/–, TLR2
–/–,
or MyD88
–/– mice, we have demonstrated that the
ability of SEA to modulate DC activation is MyD88 independent
and requires neither TLR4 nor TLR2. Moreover, TLR2 and TLR4
are not required for SEA-pulsed DCs to induce Th2 responses
in naïve mice.

INTRODUCTION
Helminth parasites, which colonize organ systems as diverse
as the lymphatics, gastrointestinal tract, and vasculature,
have evolved multiple immunomodulatory mechanisms to evade host
immune responses (
20). A delicate balance is required in these
chronic infections to establish parasite survival without eliciting
lethal immunopathology. This balance is illustrated in schistosomiasis,
which is caused by the trematode
Schistosoma mansoni and causes
chronic morbidity in more than 200 million people (
24). Following
infection, worms migrate to the portal vasculature, where they
mature and pair. This early phase of infection is characterized
by a Th1 response. After worm pairing, females lay eggs that
cross the intestinal barrier to be excreted in the feces. However,
some eggs become lodged in the intestinal wall and liver sinusoids,
where soluble egg antigens (SEA) induce a polarized Th2 response
(
23). The Th2 response correlates with the downmodulation of
the initial proinflammatory Th1 response to migrating immature
worms and results in granuloma formation. Failure to switch
to a Th2 response leads to hepatotoxic liver disease and host
death (
3,
6,
11).
The mechanism by which host innate immune cells recognize SEA remains unclear. Pathogens such as bacteria, viruses, and intracellular parasites express conserved molecular signatures that are shared within classes of pathogens and their free-living relatives. These are recognized by highly conserved pattern recognition receptors (PRRs) expressed by innate defense cells, including dendritic cells (DCs) and macrophages. PRRs include C-type lectins and Toll-like receptors (TLRs) (10, 32). TLRs are the most well-described PRRs, and DC activation by TLR ligation is considered to play a major role in the coordination of innate and adaptive immune responses during infection (22). Typically, the ligation of TLRs initiates a proinflammatory program, which promotes innate defense mechanisms and adaptive Th1 or Th17 immune responses to the invasive pathogens (22). There is evidence, however, that lipopolysaccharide (LPS) activation of TLR4 can induce DCs to support the development of Th2 responses (5, 15).
Emerging data have demonstrated that phospholipids or glycoproteins unique to extracellular helminths ligate TLRs to induce an anti-inflammatory and Th2-inducing antigen-presenting cell phenotype. A phosphorylcholine-containing glycoprotein, ES-62, from the nematode Acanthocheilonema viteae, has been shown to induce a polarized Th2 response and to work via TLR4 to modulate antigen-presenting cell activation by a variety of TLR ligands (7, 33). There is also evidence that S. mansoni products can stimulate antigen-presenting cells through TLRs. A lipid fraction from S. mansoni eggs containing lysophosphatidylserine has been shown, in a TLR2-dependent mechanism, to induce the activation of DCs that promote Th2 and regulatory T-cell development (28), and lacto-N-fucopentaose III (LNFPIII), a synthetic copy of a schistosome egg glycan, has been shown to promote Th2 differentiation by DCs via a TLR4-dependent pathway (26).
Here, using gene-targeted mice, we demonstrate conclusively that the anti-inflammatory and Th2-inducing characteristics of SEA are MyD88 independent and require neither TLR2 nor TLR4.

MATERIALS AND METHODS
Animals and reagents.
C57BL/6 (B6), TLR2
–/– (B6.129-
Tlr2tm1Kir/J), C57BL/10
(B10), and TLR4
–/– (C57BL/10ScNJ) mice were purchased
from The Jackson Laboratory (Bar Harbor, ME). MyD88
–/– mice were bred and maintained under specific-pathogen-free conditions
at the University of Pennsylvania and were a gift from Larry
Turka. DC activation was induced by the following TLR ligands:
Pam-3Cys (5 µg/ml; EMC Microcollections GmbH, Tübingen,
Germany), poly(I:C) (10 µg/ml; InvivoGen, San Diego, CA),
LPS (100 ng/ml;
Escherichia coli serotype 0111:B4; Sigma-Aldrich,
St. Louis, MO), or CpG ODN 1826 (10 µg/ml; Coley Pharmaceutical
Group, Ottawa, ON, Canada). SEA was prepared aseptically as
previously described and used at 50 µg/ml (
19). Antibody
(Ab) specific for the interleukin-10 receptor (IL-10R) (clone
1B1.3a; BD Pharmingen, San Diego, CA) was used at 10 µg/ml
to block endogenous IL-10 consumption.
Generation of DCs.
Bone marrow cells were aseptically collected from the femurs and tibias of wild-type (WT), TLR2–/–, TLR4–/–, or MyD88–/– mice, and 1 x 106 cells were cultured in untreated six-well plates for 8 to 10 days in 3 ml of complete DC medium consisting of RPMI (Mediatech Inc., Herndon, VA), 100 U/ml penicillin-streptomycin (Mediatech), 2 mM L-glutamine (Mediatech), 10% fetal bovine serum (HyClone, Logan, UT), and 0.05 mM 2-mercaptoethanol (Sigma) and in the presence of 20 ng/ml granulocyte-macrophage colony-stimulating factor (PeproTech, Rocky Hill, NJ). On day 3 of culture, 3 ml of fresh medium was added, and on days 6 and 8, 3 ml of medium was removed and replaced with fresh medium. Nonadherent cells, which were routinely between 80 to 85% CD11c+, were collected and incubated at 4 x 105 cells/well in round-bottom 96-well plates under the conditions indicated.
Measurement of cytokine production by DCs.
Cytokine enzyme-linked immunosorbent assays (ELISAs) were performed on 24-h cell-free supernatants by use of paired monoclonal Abs (MAbs) in combination with recombinant cytokine standards (BD Pharmingen) as described previously (19). Statistical significance was determined by a two-tailed Student t test with equal variance. Intracellular cytokine levels were assessed by the addition of brefeldin A (BD Pharmingen) to the culture for the final 4 h. Cells were surface stained with fluorescein isothiocyanate-conjugated anti-CD11c, washed, and fixed overnight in 1% formaldehyde (Sigma). The following day, cells were permeabilized with 0.1% saponin (Sigma) and incubated with phycoerythrin-conjugated anti-IL-12 MAb (clone C11.5; BD Pharmingen). Samples were washed twice and collected using a FACSCalibur flow cytometer (BD Pharmingen). Data were analyzed using FlowJo Software (Tree Star, Ashland, OR).
T-cell response priming in vivo.
Immature B6, TLR2–/–, B10, and TLR4–/– DCs were harvested on day 9 or 10 and pulsed overnight in medium alone or with 50 µg/ml SEA. Subsequently, DCs were washed twice in Hanks' balanced salt solution (Mediatech) to remove excess antigen, resuspended in Hanks' balanced salt solution, and injected intraperitoneally with a sterile 25-gauge needle into naïve mice (5 x 105 DC/mouse). After 7 days, single-cell suspensions (1 x 107/ml) of splenocytes from immunized mice were restimulated in vitro with SEA (50 µg/ml) as described previously (19). After 3 days, supernatants were collected for the determination of antigen-specific cytokine production by ELISA. Significance was established by a paired, two-tailed Student t test.

RESULTS
SEA-mediated suppression of CpG-induced DC activation is TLR4 independent.
Previous work has demonstrated that SEA can suppress TLR ligand-induced
DC activation by modulating the production of proinflammatory
cytokines like IL-12 and preventing the maximal upregulation
of DC maturation markers, such as major histocompatibility complex
type II (MHC-II), CD80, and CD86 (
4,
16,
34). Furthermore, other
helminth products have been shown to act directly through TLR4
to alter DC maturation in response to inflammatory TLR ligands
(
7,
26). To determine whether the modulation of DC activation
by SEA is TLR4 dependent, DCs were generated from the bone marrow
of TLR4-deficient mice and congenic control WT B10 mice and
pulsed with LPS and, as a control, the TLR9 ligand CpG alone
or in the presence of SEA. DC maturation was assessed by MHC-II
surface expression at 4 h, intracellular IL-12 production at
6 h, and secreted IL-12 protein levels at 24 h poststimulation.
As expected based on previous findings, SEA alone did not alter
MHC-II expression on, or induce IL-12 production by, WT or TLR4
–/– DCs (Fig.
1) (
16,
18). In contrast, WT DCs upregulated MHC-II
and IL-12 production in response to LPS and CpG (Fig.
1). When
WT DCs were pulsed simultaneously with SEA and either LPS or
CpG, the upregulation of MHC-II was significantly inhibited
(Fig.
1A). Moreover, SEA suppressed CpG-induced MHC-II upregulation
in the TLR4
–/– DCs (Fig.
1A). In WT DCs, SEA was
capable of suppressing IL-12 production induced by either LPS
or CpG. LPS stimulation of TLR4
–/– DCs induced only
low levels of MHC-II and IL-12p40 expression (this is consistent
with previous reports demonstrating that commercially available
LPS contains TLR2 ligands [
12]). Nonetheless, TLR4-independent
LPS-induced IL-12 production was suppressed by SEA (Fig.
1B).
In addition, CpG-induced IL-12 production was inhibited by SEA
in the TLR4
–/– DCs (Fig.
1B). IL-12p40 was also
measured in the 24-h culture supernatant DCs pulsed with TLR
ligands either alone or in the presence of SEA (Fig.
1C). Consistent
with the intracellular staining data, SEA suppressed LPS- and
CpG-induced IL-12p40 production in both B10 and TLR4
–/– DCs. These results demonstrate that the anti-inflammatory effects
of SEA are TLR4 independent.
SEA-mediated suppression of CpG-induced DC activation is TLR2 independent.
Previous work demonstrated that TLR2 ligands induce the phosphorylation
of the mitogen-activated protein kinase family member extracellular
signal-regulated kinase, which results in the activation of
the transcription factor c-Fos and the suppression of IL-12
production, thereby biasing the immune response toward a Th2
phenotype (
1). Of interest in this context is that a TLR2 ligand
has been identified in the lipid fractions of extracts from
egg and adult stages of
S. mansoni (
28). To determine if the
suppression of TLR ligand-induced DC activation by SEA is dependent
on TLR2, WT B6 and TLR2
–/– B6 DCs were pulsed with
the TLR2 and TLR9 ligands Pam3Cys (P3C) and CpG, respectively.
Again, we observed no signs of DC activation following pulsing
with SEA (Fig.
2). As expected, in WT DCs both P3C and CpG induced
increased MHC-II expression (Fig.
2A) and production of IL-12
as measured by intracellular staining at 6 h (Fig.
2B) and by
ELISA at 24 h (Fig.
2C). The ability of SEA to block activation
was particularly apparent when the levels of IL-12p40 in DC
supernatants were measured (Fig.
2C). For TLR2
–/– DCs, background levels of MHC-II expression were high but nevertheless
increased when CpG was added (Fig.
2A). MHC-II levels, although
not IL-12 production, also increased in these cells in response
to P3C (Fig.
2A), which was unexpected and presumably reflects
the contamination of P3C with another TLR ligand, such as endotoxin.
Nevertheless, SEA was able to suppress TLR2
–/– DC
activation by CpG, and again this was most apparent as reduced
levels of IL-12p40 in the supernatants of DCs cultured with
CpG plus SEA versus those cultured with CpG alone (Fig.
2C).
These data indicate that the suppressive effects of SEA are
not mediated by TLR2.
SEA augments CpG-stimulated IL-10 production independently of TLR4 and TLR2.
Previous data have demonstrated that the SEA-mediated suppression
of TLR ligand-induced IL-12 production by DCs is accompanied
by a corresponding augmentation of IL-10 production (
16). The
TLR9 ligand CpG was used to examine whether this augmentation
of IL-10 production by SEA occurs in the absence of TLR4. SEA
alone does not induce IL-10 production (Fig.
3). However, as
expected, B10 WT and TLR4
–/– DCs and B6 WT and TLR2
–/– DCs pulsed with CpG produced IL-10 (Fig.
3). IL-10 accumulation
in the culture supernatants was increased when a MAb that blocks
the IL-10R was included in the cultures to inhibit endogenous
consumption of this cytokine (Fig.
3). When WT, TLR2
–/–,
or TLR4
–/– DCs were copulsed with CpG and SEA, the
TLR ligand-induced production of IL-10 was increased, and this
was particularly evident when the IL-10R was blocked (Fig.
3).
These data provide further support for the ability of SEA to
modulate TLR ligand-induced DC activation independently of TLR2
or TLR4.
SEA pulsed TLR–/– DCs induce an antigen-specific Th2 response in naïve mice.
We and others have shown that immature bone marrow-derived DCs
pulsed with SEA induce an antigen-specific Th2 response in naïve
mice (
4,
19). Previously, it has been shown that the
S. mansoni carbohydrate LNFPIII produces a Th2-inducing DC phenotype in
a TLR4-dependent manner (
26). In contrast, the TLR2 ligand from
the lipid portion of SEA has been shown to induce a tolerogenic
DC phenotype in humans (
29). To specifically ask whether SEA-pulsed
DCs could induce a Th2 response despite the lack of TLR2 or
TLR4, we pulsed immature DCs from WT and TLR
–/– mice with SEA and adoptively transferred them into naïve
syngeneic WT mice. We found that splenocytes from mice injected
with SEA-pulsed DCs from either WT or TLR4
–/– mice
made IL-5 upon restimulation with SEA (Fig.
4A). Similarly,
splenocytes from mice injected with SEA-pulsed DCs derived from
WT or TLR2
–/– mice made IL-5 upon restimulation
with SEA (Fig.
4B). We routinely measured more IL-5 when using
the B10 strain of mice (Fig.
4B) than when using the B6 strain
(Fig.
4A), perhaps indicating a strain-dependent propensity
of B10 mice to mount stronger Th2 responses. We were unable
to measure gamma interferon in antigen-restimulated cultures
(data not shown). These results demonstrate that neither TLR2
nor TLR4 is required for SEA to condition DCs to polarize T-cell
responses in a Th2 direction.
SEA suppresses TLR ligand-induced IL-12 production in MyD88–/– DCs.
The adaptor molecule MyD88 associates with the cytoplasmic domains
of most TLRs, except for TLR3, after ligand binding and recruits
the IRAKs and TRAF6, resulting in their activation and the subsequent
downstream activation of NF-

B and mitogen-activated protein
kinases. Another adaptor molecule, TRIF, is responsible for
TLR3- and TLR4- MyD88-independent activation of interferon regulatory
factor 3 (IRF3) and NF-

B (
25). We examined whether SEA could
suppress DC activation in a MyD88-independent manner. WT and
MyD88
–/– DC were pulsed with LPS (the TLR4 ligand
that activates both MyD88- and TRIF-dependent pathways) or with
the TRIF-dependent TLR3 ligand poly(I:C) or the MyD88-dependent
TLR9 ligand CpG. We found that WT DCs pulsed with LPS or CpG
produced high levels of IL-12p40 and IL-12p70, but when DCs
were copulsed with LPS or CpG plus SEA, cytokine production
was dramatically suppressed (Fig.
5A and B). As expected, MyD88
–/– DCs did not make IL-12p40 or IL-12p70 in response to the TLR9
ligand CpG (Fig.
5A and B). However, MyD88
–/– DCs
pulsed with LPS or poly(I:C) made low levels of IL-12p40 and
IL-12 p70 (Fig.
5A and B), presumably via the TRIF-dependent
pathway. The MyD88-independent production of IL-12 was potently
suppressed by SEA (Fig.
5A and B). These findings indicate that
the SEA-mediated suppression of TLR-induced DC activation is
MyD88 independent.

DISCUSSION
We have demonstrated that the SEA-mediated modulation of TLR
ligand-induced DC activation occurs independently of TLR2, TLR4,
and, most importantly, MyD88. These data suggest that SEA binds
to an as-yet-unknown PRR that antagonizes the proinflammatory
response initiated by TLR ligands. Importantly, SEA-pulsed TLR2
–/– and TLR4
–/– DCs are capable of inducing a polarized
Th2 response in naïve mice. These data, together with the
recently published report that schistosome infection of MyD88
–/– mice leads to a normal Th2 response (
18), indicate that SEA
does not depend on novel signaling pathways activated by TLR2
or TLR4 to elicit Th2 responses, as has been suggested by some
(
27).
To establish chronic infections, many helminths have evolved immunomodulatory mechanisms to subvert the host immune system. The filarial nematode A. viteae secretes the immunomodulatory molecule ES-62, which, similar to SEA, has been shown to promote Th2 polarization through its interaction with antigen-presenting cells. Importantly, ES-62 also suppresses TLR ligand-induced DC activation (7-9, 33). ES-62 modulates TLR-induced DC activation through a nonclassical interaction with TLR4 (21). Additionally, the synthetic S. mansoni-related glycan LNFPIII has been reported to condition DCs, in a TLR4-dependent manner, to become capable of inducing Th2 responses (26). Therefore, we assessed the role of TLR4 in the SEA-mediated modulation of TLR ligand-induced DC activation. We found that the presence of TLR4 was not required for SEA to suppress the TLR-induced upregulation of MHC-II and the production of the proinflammatory cytokine IL-12. Similarly, the SEA-mediated augmentation of CpG-induced IL-10 production was intact in TLR4-deficient DCs, as was the ability of SEA-pulsed TLR4–/– DCs to induce a polarized Th2 response. The data presented here illustrate that the important interactions between SEA and DCs do not require the expression of TLR4 by the latter. In this context, it is important to note that S. mansoni products have not been documented to possess the phosphorylcholine moieties that are responsible for the immunomodulatory activity of ES-62, nor does SEA alone induce low levels of proinflammatory cytokine production as does ES-62, suggesting that this latter activity is unique to helminths that express phosphorylcholine-containing molecules and may reflect an evolutionary divergence of trematodes and filarial nematodes. The differences between our data using SEA and findings reported for LNFPIII may be due to the presence of multiple ligands and antigens in SEA versus the specific synthetic composition of LNFPIII. Furthermore, LNFPIII has not been shown to alter TLR-induced DC activation, suggesting that other SEA components are responsible for this anti-inflammatory property.
TLR2 was implicated as a possible receptor for the immunomodulatory activity of SEA by the findings that schistosome-derived lipids activate human DCs via TLR2 to elicit a tolerogenic phenotype (28). Moreover, during experimental infections of mice, the absence of TLR2 was associated with a defect in T-regulatory-cell response induction, which resulted in stronger, more prolonged Th1 responses and reduced Th2 immune responses, leading to increased immunopathology (17). In other studies, TLR2 ligands have been shown to elicit a DC maturation status that differs from that induced by TLR4 and TLR5 (1). This difference is characterized by enhanced extracellular signal-regulated kinase phosphorylation, suppressed IL-12p70 production, and the induction of a Th2 rather than a Th1 polarized immune response (1). Nevertheless, in our hands, the immunomodulatory characteristics of SEA were intact in TLR2–/– DCs, and SEA-pulsed TLR2–/– DCs were capable of inducing an antigen-specific Th2 response in naïve mice, suggesting that TLR2 is not the receptor through which SEA achieves these effects. However, it should be stressed that SEA, a phosphate-buffered saline-soluble extract of eggs, is unlikely to contain the immunomodulatory lipid described by van der Kleij and colleagues (28), and thus our results cannot exclude a role for this schistosome molecule, or TLR2, on DCs, or on cells other than DCs, in the overall response of the host to infection.
To more broadly address the question of a role for TLRs in the immunomodulatory activity of SEA, we used MyD88–/– DCs, which eliminates the possibility that SEA is signaling through TLR1, TLR2, TLR5, TLR6, TLR7, TLR8, or TLR9 in a conventional manner. We found that SEA suppresses the LPS- and poly(I:C)-induced production of IL-12p40 and IL-12p70 by MyD88–/– DCs, demonstrating not only the MyD88-independent immunomodulatory activity of SEA but also that SEA suppresses TLR ligand-induced, TRIF-dependent DC activation.
Although there is evidence that double-stranded RNA in SEA ligates TLR3, thereby resulting in STAT1 activation (2), it is unlikely that the immunomodulatory components of SEA bind to TLR3 for two reasons: first, in our hands, poly(I:C) did not inhibit LPS-induced IL-12 production (unpublished observations); and second, schistosome double-stranded RNA has been shown to result in the production of type I interferons rather than to inhibit DC activation (2). This suggests that the SEA-mediated modulation of DC activation occurs in a TRIF-independent fashion. The exclusion of a direct role for TLRs and their adaptor proteins in the SEA-mediated modulation of DC function is further supported by reports that the ability of SEA to condition DCs to prime Th2 responses in vitro is MyD88 and TLR4 independent (13) and that Th2 responses are intact in SEA-injected MyD88–/– mice (14). Moreover, Th2 responses do develop in MyD88–/– (18), TLR2–/– (17), and TLR3–/– (30) mice infected with S. mansoni. Thus, although it remains possible that SEA modulates DC activation via TLRs in a nontraditional manner, the data suggest that PRRs other than TLRs are responsible for this activity. Likely candidates for such PRRs are C-type lectins. Recent reports have implicated C-type lectins in the ability of antigen-presenting cells to respond to SEA and specifically in the ability of these receptors to limit DC activation (31).
We have shown here that SEA does not utilize TLR2, TLR4, or MyD88 to exert its immunomodulatory activity on TLR-induced DC activation. In addition, the expression of neither TLR2 nor TLR4 on DCs is required for SEA to induce a polarized Th2 response. The data support the view that PRRs other than TLRs are crucial in the recognition of SEA components and the initiation of signaling events that intersect with, and modulate, TLR signaling in DCs: C-type lectins are prime candidates for the PRRs that play this role (32). This is logical, as pathogens are encountered as complex mixtures of molecules that may interact with multiple receptors to elicit a specific response or manipulate the host's response to benefit the pathogens themselves. In the case of schistosomes, antigen secretions, such as those represented in SEA, with many possible immunomodulatory ligands, may have evolved to suppress IL-12 production and promote a Th2 response, favoring the survival of both pathogen and host.

ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grant
AI53825 (to E.J.P.). C.M.K. was supported by National Institutes
of Health Parasitology training grant AI07532. Schistosome life
stages for this work were supplied through National Institutes
of Health grant NO155270.

FOOTNOTES
* Corresponding author. Mailing address: Department of Pathobiology, School of Veterinary Medicine, 318 Hill Pavilion, 380 S. University Ave., Philadelphia, PA 19104. Phone: (215) 573-3493. Fax: (215) 746-2295. E-mail:
ejpearce{at}mail.med.upenn.edu 
Published ahead of print on 29 September 2008. 
Editor: J. F. Urban, Jr.

REFERENCES
1 - Agrawal, S., A. Agrawal, B. Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, and B. Pulendran. 2003. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171:4984-4989.[Abstract/Free Full Text]
2 - Aksoy, E., C. S. Zouain, F. Vanhoutte, J. Fontaine, N. Pavelka, N. Thieblemont, F. Willems, P. Ricciardi-Castagnoli, M. Goldman, M. Capron, B. Ryffel, and F. Trottein. 2005. Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J. Biol. Chem. 280:277-283.[Abstract/Free Full Text]
3 - Brunet, L. R., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777-785.[Abstract]
4 - Cervi, L., A. S. MacDonald, C. Kane, F. Dzierszinski, and E. J. Pearce. 2004. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J. Immunol. 172:2016-2020.[Abstract/Free Full Text]
5 - Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.[Abstract/Free Full Text]
6 - Fallon, P. G., E. J. Richardson, G. J. McKenzie, and A. N. McKenzie. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164:2585-2591.[Abstract/Free Full Text]
7 - Goodridge, H. S., F. A. Marshall, K. J. Else, K. M. Houston, C. Egan, L. Al-Riyami, F. Y. Liew, W. Harnett, and M. M. Harnett. 2005. Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62. J. Immunol. 174:284-293.[Abstract/Free Full Text]
8 - Goodridge, H. S., F. A. Marshall, E. H. Wilson, K. M. Houston, F. Y. Liew, M. M. Harnett, and W. Harnett. 2004. In vivo exposure of murine dendritic cell and macrophage bone marrow progenitors to the phosphorylcholine-containing filarial nematode glycoprotein ES-62 polarizes their differentiation to an anti-inflammatory phenotype. Immunology 113:491-498.[CrossRef][Medline]
9 - Goodridge, H. S., E. H. Wilson, W. Harnett, C. C. Campbell, M. M. Harnett, and F. Y. Liew. 2001. Modulation of macrophage cytokine production by ES-62, a secreted product of the filarial nematode Acanthocheilonema viteae. J. Immunol. 167:940-945.[Abstract/Free Full Text]
10 - Hemmi, H., and S. Akira. 2005. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86:120-135.[Medline]
11 - Herbert, D. R., C. Holscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, B. Claussen, I. Forster, and F. Brombacher. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20:623-635.[CrossRef][Medline]
12 - Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 165:618-622.[Abstract/Free Full Text]
13 - Jankovic, D., M. C. Kullberg, P. Caspar, and A. Sher. 2004. Parasite-induced Th2 polarization is associated with down-regulated dendritic cell responsiveness to Th1 stimuli and a transient delay in T lymphocyte cycling. J. Immunol. 173:2419-2427.[Abstract/Free Full Text]
14 - Jankovic, D., M. C. Kullberg, S. Hieny, P. Caspar, C. M. Collazo, and A. Sher. 2002. In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(–/–) setting. Immunity 16:429-439.[CrossRef][Medline]
15 - Kaisho, T., K. Hoshino, T. Iwabe, O. Takeuchi, T. Yasui, and S. Akira. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support T(h) 2 cell differentiation. Int. Immunol. 14:695-700.[Abstract/Free Full Text]
16 - Kane, C. M., L. Cervi, J. Sun, A. S. McKee, K. S. Masek, S. Shapira, C. A. Hunter, and E. J. Pearce. 2004. Helminth antigens modulate TLR-initiated dendritic cell activation. J. Immunol. 173:7454-7461.[Abstract/Free Full Text]
17 - Layland, L. E., R. Rad, H. Wagner, and C. U. da Costa. 2007. Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2. Eur. J. Immunol. 37:2174-2184.[CrossRef][Medline]
18 - Layland, L. E., H. Wagner, and C. U. da Costa. 2005. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Eur. J. Immunol. 35:3248-3257.[CrossRef][Medline]
19 - MacDonald, A. S., A. D. Straw, B. Bauman, and E. J. Pearce. 2001. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J. Immunol. 167:1982-1988.[Abstract/Free Full Text]
20 - Maizels, R. M., A. Balic, N. Gomez-Escobar, M. Nair, M. D. Taylor, and J. E. Allen. 2004. Helminth parasites—masters of regulation. Immunol. Rev. 201:89-116.[CrossRef][Medline]
21 - Melendez, A. J., M. M. Harnett, P. N. Pushparaj, W. S. Wong, H. K. Tay, C. P. McSharry, and W. Harnett. 2007. Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat. Med. 13:1375-1381.[Medline]
22 - Pasare, C., and R. Medzhitov. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560:11-18.[Medline]
23 - Pearce, E. J., C. M. Kane, J. Sun, J. J. Taylor, A. S. McKee, and L. Cervi. 2004. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol. Rev. 201:117-126.[CrossRef][Medline]
24 - Pearce, E. J., and A. S. MacDonald. 2002. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2:499-511.[CrossRef][Medline]
25 - Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.[Abstract/Free Full Text]
26 - Thomas, P. G., M. R. Carter, O. Atochina, A. A. Da'Dara, D. Piskorska, E. McGuire, and D. A. Harn. 2003. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J. Immunol. 171:5837-5841.[Abstract/Free Full Text]
27 - Thomas, P. G., and D. A. Harn, Jr. 2004. Immune biasing by helminth glycans. Cell. Microbiol. 6:13-22.[CrossRef][Medline]
28 - van der Kleij, D., E. Latz, J. F. Brouwers, Y. C. Kruize, M. Schmitz, E. A. Kurt-Jones, T. Espevik, E. C. de Jong, M. L. Kapsenberg, D. T. Golenbock, A. G. Tielens, and M. Yazdanbakhsh. 2002. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277:48122-48129.[Abstract/Free Full Text]
29 - van der Kleij, D., A. H. van den Biggelaar, Y. C. Kruize, K. Retra, Y. Fillie, M. Schmitz, P. G. Kremsner, A. G. Tielens, and M. Yazdanbakhsh. 2004. Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. J. Infect. Dis. 189:1044-1051.[CrossRef][Medline]
30 - Vanhoutte, F., L. Breuilh, J. Fontaine, C. S. Zouain, T. Mallevaey, V. Vasseur, M. Capron, S. Goriely, C. Faveeuw, B. Ryffel, and F. Trottein. 2007. Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology. Microbes Infect. 9:1606-1613.[Medline]
31 - van Liempt, E., S. J. van Vliet, A. Engering, J. J. Garcia Vallejo, C. M. Bank, M. Sanchez-Hernandez, Y. van Kooyk, and I. van Die. 2007. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. Mol. Immunol. 44:2605-2615.[CrossRef][Medline]
32 - van Vliet, S. J., J. den Dunnen, S. I. Gringhuis, T. B. Geijtenbeek, and Y. van Kooyk. 2007. Innate signaling and regulation of dendritic cell immunity. Curr. Opin. Immunol. 19:435-440.[CrossRef][Medline]
33 - Whelan, M., M. M. Harnett, K. M. Houston, V. Patel, W. Harnett, and K. P. Rigley. 2000. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164:6453-6460.[Abstract/Free Full Text]
34 - Zaccone, P., Z. Fehervari, F. M. Jones, S. Sidobre, M. Kronenberg, D. W. Dunne, and A. Cooke. 2003. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur. J. Immunol. 33:1439-1449.[CrossRef][Medline]
Infection and Immunity, December 2008, p. 5754-5759, Vol. 76, No. 12
0019-9567/08/$08.00+0 doi:10.1128/IAI.00497-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Correale, J., Farez, M.
(2009). Helminth Antigens Modulate Immune Responses in Cells from Multiple Sclerosis Patients through TLR2-Dependent Mechanisms. J. Immunol.
183: 5999-6012
[Abstract]
[Full Text]